Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Stock Information for Palladyne AI Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Palladyne AI Corp.

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
Eyenovia Provides Development Update on Optejet User Filled Device (UFD)
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.